Autopsy report · NCT01568216

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Toxic Epidermal Necrolysis”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months before it started.
Ran for about 1 year 1 month before it stopped.
121 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Amgen
Sponsor type: Industry
Conditions: Schizophrenia
Interventions: AMG 747; Placebo
Participants: 121
Sites: 38
Countries: Australia, Canada, New Zealand, Russia, Singapore, Spain, United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.